Table of Content


1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Incidence of Uterine Diseases and Abnormalities
4.2.2 Growing Demand of Minimally Invasive Treatment
4.2.3 Technological Advancements Leading to Enhanced Applications
4.3 Market Restraints
4.3.1 Risk of Infection from Hysteroscopes
4.3.2 Lack of Trained Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Rigid Non-Video Hysteroscopes
5.1.2 Flexible Non-Video Hysteroscopes
5.2 By Application
5.2.1 Polypectomy
5.2.2 Myomectomy
5.2.3 Endometrial Ablation
5.2.4 Others
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Services
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 CooperSurgical Inc.
6.1.3 Hologic Inc.
6.1.4 Karl Storz SE & Co. KG
6.1.5 MedGyn Products Inc
6.1.6 Medtronic PLC
6.1.7 Olympus Medical Corporation
6.1.8 Richard Wolf GmbH
6.1.9 Stryker Corporation
6.1.10 Xion Medical GmbH


7 MARKET OPPORTUNITIES AND FUTURE TRENDS